Health Care & Life Sciences » Pharmaceuticals | HanAll Biopharma Co. Ltd.

HanAll Biopharma Co. Ltd.

HanAll Biopharma Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW115.45
Market Cap
KRW1.43 T
Shares Outstanding
52.24 M
Public Float
29.44 M

Profile

Address
43 Sangseodang 1-gil
Daejeon DE 34344
Korea, Republic Of
Employees -
Website http://www.hanall.co.kr
Updated 07/08/2019
HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceutical. Its products include medicine for digesting, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.

Financials

View All
Created with Highcharts 5.0.14HanAll Biopharma Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.21 49921 49912 65812 6587 0777 0772 0262 0265 8135 8133 3003 30020132014201520162017201805k10k15k20k25k
Created with Highcharts 5.0.14HanAll Biopharma Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.74 22874 22880 88080 88080 02380 02382 88282 88284 23184 23191 83991 839201320142015201620172018025k50k75k100k

Seung-Kook Park
Co-Chief Executive Officer & Director
Jae-Chun Yoon
Co-Chief Executive Officer & Director